Dowling & Yahnke LLC Merck & Co., Inc. Transaction History

Dowling & Yahnke LLC

$215 Million
Q3 2022

A detailed history of Dowling & Yahnke LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Dowling & Yahnke LLC holds 105,758 shares of MRK stock, worth $13.1 Million. This represents 4.24% of its overall portfolio holdings.

Number of Shares

105,758

Previous 105,658 0.09%

Holding current value

$13.1 Million

Previous $9.63 Million 5.45%

% of portfolio

4.24%

Previous 0.45%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$84.53 - $94.96 $8,453 - $9,496	100 Added 0.09%	105,758 $9.11 Million
Q2 2022 Aug 10, 2022	BUY	$83.49 - $94.64 $48,507 - $54,985	581 Added 0.55%	105,658 $9.63 Million
Q1 2022 May 04, 2022	BUY	$73.51 - $82.4 $52,559 - $58,916	715 Added 0.69%	105,077 $8.62 Million
Q4 2021 Feb 10, 2022	SELL	$72.28 - $90.54 $128,513 - $160,980	-1,778 Reduced 1.68%	104,362 $8 Million
Q3 2021 Nov 12, 2021	SELL	$71.68 - $78.83 $68,167 - $74,967	-951 Reduced 0.89%	106,140 $7.97 Million

Q2 2021 Jul 21, 2021	BUY	$70.31 - $77.77 $138,510 - $153,206	1,970 Added 1.87%	107,091 $8.33 Million
Q1 2021 Apr 29, 2021	SELL	$68.86 - $81.11 $89,173 - $105,037	-1,295 Reduced 1.22%	105,121 $8.1 Million
Q4 2020 Jan 28, 2021	BUY	$71.77 - $79.65 $415,404 - $461,014	5,788 Added 5.75%	106,416 $8.71 Million
Q3 2020 Oct 19, 2020	BUY	$73.18 - $82.95 $18,807 - $21,318	257 Added 0.26%	100,628 $8.35 Million
Q2 2020 Jul 31, 2020	BUY	$70.42 - $80.13 $43,167 - $49,119	613 Added 0.61%	100,371 $7.76 Million
Q1 2020 May 15, 2020	SELL	$63.36 - $87.82 $180,195 - $249,760	-2,844 Reduced 2.77%	99,758 $7.68 Million
Q4 2019 Jan 27, 2020	SELL	$77.58 - $87.54 $200,854 - $226,641	-2,589 Reduced 2.46%	102,602 $9.33 Million
Q3 2019 Oct 29, 2019	BUY	$76.08 - $82.93 $261,563 - $285,113	3,438 Added 3.38%	105,191 $8.86 Million
Q2 2019 Jul 22, 2019	SELL	$69.84 - $81.59 $109,020 - $127,361	-1,561 Reduced 1.51%	101,753 $8.53 Million
Q1 2019 Apr 30, 2019	BUY	$69.58 - $79.36 $228,848 - $261,015	3,289 Added 3.29%	103,314 $8.59 Million
Q4 2018 Jan 24, 2019	BUY	$65.24 - $75.71 $130,806 - $151,798	2,005 Added 2.05%	100,025 $7.94 Million
Q3 2018 Oct 30, 2018	SELL	$57.69 - $67.84 $86,477 - $101,692	-1,499 Reduced 1.51%	98,020 $6.95 Million
Q2 2018 Jul 30, 2018	SELL	$50.83 - $59.72 $66,282 - $77,874	-1,304 Reduced 1.29%	99,519 $6.04 Million
Q1 2018 May 01, 2018	SELL	$50.96 - $59.23 $62,731 - $72,912	-1,231 Reduced 1.21%	100,823 $5.49 Million
Q4 2017 Feb 02, 2018	SELL	$51.62 - $61.64 $5.49 Million - $6.55 Million	-106,322 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$58.67 - $63.13 $6.24 Million - $6.71 Million	106,322	106,322 $6.81 Million

Others Institutions Holding MRK

# of Institutions

3,766

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $314B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dowling & Yahnke LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dowling & Yahnke LLC with notifications on news.

Account

Dowling & Yahnke LLC Merck & Co., Inc. Transaction History